Chemical Structure : BAY 11-7082
CAS No.: 19542-67-7
货号: PC-43543Not For Human Use, Lab Use Only.
BAY 11-7082 is a NF-κB inhibitor that selectively and irreversibly inhibits the TNF-α-inducible phosphorylation of IκBα (IC50=10 uM), also inhibits ubiquitin-specific protease USP7 and USP21 with IC50 of 0.19 uM and 0.96 uM, respectively.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥980 | In stock | |
50 mg | ¥1480 | In stock | |
100 mg | ¥2580 | In stock | |
250 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
BAY 11-7082 is a NF-κB inhibitor that selectively and irreversibly inhibits the TNF-α-inducible phosphorylation of IκBα (IC50=10 uM), also inhibits ubiquitin-specific protease USP7 and USP21 with IC50 of 0.19 uM and 0.96 uM, respectively.
BAY 11-7082 induces apoptosis of HTLV-I-infected T-cell lines but only negligible apoptosis of HTLV-I-negative T cells, rapidly and efficiently reduces the DNA binding of NF-κB in HTLV-I-infected T-cell lines and down-regulates the expression of the antiapoptotic gene, Bcl-xL, regulated by NF-κB.
BAY 11-7082 selectively inhibits Tax-induced NF-κB activity in a human T-cell line.
BAY 11-7082 exerts effects by inactivating the E2-conjugating enzymes Ubc (ubiquitin conjugating) 13 and UbcH7 and the E3 ligase LUBAC (linear ubiquitin assembly complex), thereby preventing the formation of Lys63-linked and linear polyubiquitin chains.
BAY 11-7082 prevents ubiquitin conjugation to Ubc13 and UbcH7 by forming a covalent adduct with their reactive cysteine residues.
分子量 | 207.249 | |
分子式 | C10H9NO2S | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
2-Propenenitrile, 3-[(4-methylphenyl)sulfonyl]-, (2E)- |
1. Thévenod F, et al. J Biol Chem. 2000 Jan 21;275(3):1887-96.
2. Mori N, et al. Blood. 2002 Sep 1;100(5):1828-34.
3. Ritorto MS, et al. Nat Commun. 2014 Aug 27;5:4763.
4. Strickson S, et al. Biochem J. 2013 May 1;451(3):427-37.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright